Brinda Krish, DO

Call
Website

Advertisement

Photos

1800 Orleans St
Baltimore, MD 21287
Dr. Linda Chi Hang Chu is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. Her clinical expertise includes body CT, MRI and US. Her research interests include abdominal imaging, cancer imaging, radiomics, and artificial intelligence.Dr. Chu graduated from the University of Toronto in 2003 and was awarded the Governor General's Silver Medal, the highest academic achievement from the undergraduate program. She earned her medical degree as a member of AOA and phi beta kappa from Johns Hopkins University in Baltimore, MD in 2007. She completed her Diagnostic Radiology residency and body MRI fellowship at Johns Hopkins Hospital. Dr. Chu joined the Johns Hopkins faculty in 2013.
Request an Appointment
Owner verified
See a problem?

You might also like

Jochen Steppan, MD
Internal medicine practitioners

Jochen Steppan, MD

Dr. Jochen Steppan's research focuses on the basic science aspects of vascular stiffness, an important predictor of aging-associated cardiovascular morbidity and pulmonary hypertension. In a collaborative effort with a team of cardiovascular biologists and physiologists, Dr. Steppan addresses important pathways of aging, associated changes in nitric oxide signaling, the nitroso-redox milieu, endothelial function, extracellular matrix composition and vascular reactivity. The goal of these studies is to characterize and describe the underlying basic vascular pathophysiology, and importantly to move those studies into the clinical realm to ultimately prevent, halt, or even reverse aging-associated vascular stiffness and pulmonary hypertension. This approach has been awarded with a SCA/IARS Mid-Career Award and an NIH K08 Award, to evaluate a novel target: LOXL2 (lysine-oxidase-like-2), which may be intimately involved in the development or progression of pulmonary hypertension. These studies will advance the understanding of LOXL2's role in the lung vasculature and may lead to the characterization of a novel therapeutic target, which is of critical importance for the treatment of this deadly disease. Furthermore, Dr. Steppan is a co-investigator of a R01, evaluating LOXL2 in aging-associated vascular stiffness. Lastly, he holds intramural awards to evaluate vascular stiffness in patients with mitral valve disease and to characterize the mechanisms of action of LOXL2 in PH.
United StatesMarylandBaltimoreBrinda Krish, DO

Yext

Advertisement